StonvexLoading…
StonvexStonvexStonvexCore line items from IQST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $316.90M | $283.22M | $144.50M | $93.20M |
Operating Income | $-4.25M | $-834.06K | $-315.50K | $-3.19M |
Net Income | $-8.51M | $-5.18M | $-763.26K | $-5.97M |
EPS (Diluted) | $-2.86 | $-2.86 | $-0.01 | $-0.04 |
Total Assets | $51.09M | $79.01M | $22.16M | $12.55M |
Total Liabilities | $34.81M | $67.11M | $14.11M | $6.71M |
Cash & Equivalents | $2.16M | $2.51M | $1.36M | $1.33M |
Free Cash Flow OCF − CapEx | $-3.96M | $-3.08M | $-1.70M | $-1.88M |
Shares Outstanding | 4.67M | 2.54M | 172.13M | 161.60M |